Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
3.195
-0.185 (-5.47%)
Mar 31, 2025, 10:59 AM EDT - Market open

Corvus Pharmaceuticals Market Cap

Corvus Pharmaceuticals has a market cap or net worth of $217.69 million as of March 31, 2025. Its market cap has increased by 121.91% in one year.

Market Cap
217.69M
Enterprise Value
179.46M
1-Year Change
121.91%
Ranking
Category
Stock Price
$3.20

Market Cap Chart

Since March 23, 2016, Corvus Pharmaceuticals's market cap has decreased from $290.80M to $217.69M, a decrease of -25.14%. That is a compound annual growth rate of -3.16%.

History

DateMarket Cap% Change
Mar 28, 2025230.30M-33.01%
Dec 31, 2024343.80M298.38%
Dec 29, 202386.30M117.93%
Dec 30, 202239.60M-64.71%
Dec 31, 2021112.20M12.31%
Dec 31, 202099.90M-37.56%
Dec 31, 2019160.00M48.84%
Dec 31, 2018107.50M-50.69%
Dec 29, 2017218.00M-27.09%
Dec 30, 2016299.00M2.82%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings